Alnylam Pharmaceuticals Statistics

Total Valuation

LON:0HD2 has a market cap or net worth of GBP 45.43 billion. The enterprise value is 45.46 billion.

Market Cap	45.43B
Enterprise Value	45.46B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	132.11M
Shares Outstanding	n/a
Shares Change (YoY)	+4.82%
Shares Change (QoQ)	+5.14%
Owned by Insiders (%)	0.31%
Owned by Institutions (%)	99.71%
Float	130.25M

Valuation Ratios

The trailing PE ratio is 1,401.64 and the forward PE ratio is 42.47.

PE Ratio	1,401.64
Forward PE	42.47
PS Ratio	19.02
PB Ratio	261.07
P/TBV Ratio	261.07
P/FCF Ratio	275.85
P/OCF Ratio	229.68
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 156.89, with an EV/FCF ratio of 276.07.

EV / Earnings	1,402.77
EV / Sales	18.87
EV / EBITDA	156.89
EV / EBIT	228.83
EV / FCF	276.07

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 11.86.

Current Ratio	2.54
Quick Ratio	2.37
Debt / Equity	11.86
Debt / EBITDA	7.18
Debt / FCF	12.53
Interest Coverage	1.63

Financial Efficiency

Return on equity (ROE) is 32.73% and return on invested capital (ROIC) is 5.74%.

Return on Equity (ROE)	32.73%
Return on Assets (ROA)	3.65%
Return on Invested Capital (ROIC)	5.74%
Return on Capital Employed (ROCE)	8.03%
Revenue Per Employee	1.07M
Profits Per Employee	14,534
Employee Count	2,230
Asset Turnover	0.71
Inventory Turnover	6.83

Taxes

Income Tax	-56.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +79.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+79.46%
50-Day Moving Average	457.49
200-Day Moving Average	357.78
Relative Strength Index (RSI)	51.23
Average Volume (20 Days)	121

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.92

Income Statement

In the last 12 months, LON:0HD2 had revenue of GBP 2.39 billion and earned 32.41 million in profits. Earnings per share was 0.25.

Revenue	2.39B
Gross Profit	2.00B
Operating Income	196.92M
Pretax Income	-23.76M
Net Income	32.41M
EBITDA	238.82M
EBIT	196.92M
Earnings Per Share (EPS)	0.25

Full Income Statement

Balance Sheet

The company has 2.03 billion in cash and 2.06 billion in debt, giving a net cash position of -36.22 million.

Cash & Cash Equivalents	2.03B
Total Debt	2.06B
Net Cash	-36.22M
Net Cash Per Share	n/a
Equity (Book Value)	174.00M
Book Value Per Share	1.32
Working Capital	1.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 197.79 million and capital expenditures -33.10 million, giving a free cash flow of 164.68 million.

Operating Cash Flow	197.79M
Capital Expenditures	-33.10M
Free Cash Flow	164.68M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 83.90%, with operating and profit margins of 8.25% and 1.36%.

Gross Margin	83.90%
Operating Margin	8.25%
Pretax Margin	-1.00%
Profit Margin	1.36%
EBITDA Margin	10.00%
EBIT Margin	8.25%
FCF Margin	6.90%

Dividends & Yields

LON:0HD2 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.82%
Shareholder Yield	-4.82%
Earnings Yield	0.07%
FCF Yield	0.36%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HD2 has an Altman Z-Score of 4.46 and a Piotroski F-Score of 5.

Altman Z-Score	4.46
Piotroski F-Score	5